AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2007
Aug 10, 2007
34117_dirs_2007-08-10_5a5d71f2-af27-4124-bcbc-1049d188a4cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2007-08-08
Reporting Person: HERMS HENRY P (Director, Vice President - Finance & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-08-08 | Common Stock | M | 200000 | $0.25 | Acquired | 211575 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-08-08 | Employee Stock Option | $0.25 | M | 200000 | Disposed | 2013-05-05 | Common Stock (200000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the CopyTele, Inc. 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6